Weifeng Tang Selected Research

Weifeng Tang Research Topics

Disease

31	Neoplasms (Cancer) 11/2022 - 01/2013
13	Type 2 Diabetes Mellitus (MODY) 10/2022 - 06/2017
12	Asthma (Bronchial Asthma) 09/2022 - 01/2020
11	Esophageal Neoplasms (Esophageal Cancer) 11/2022 - 05/2012
9	Carcinogenesis 11/2022 - 01/2015
9	Inflammation (Inflammations) 04/2022 - 01/2015
7	Body Weight (Weight, Body) 10/2022 - 10/2007
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2015
6	Adenocarcinoma 12/2017 - 04/2014
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 01/2019
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2017
5	Respiratory Hypersensitivity 01/2022 - 02/2021
5	Esophageal Squamous Cell Carcinoma 08/2021 - 01/2015
4	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 07/2019
2	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 11/2022 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 11/2022 - 01/2021
2	Heart Failure 01/2022 - 01/2021
2	Pneumonia (Pneumonitis) 12/2021 - 01/2020
2	Obesity 01/2021 - 10/2007
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2015 - 01/2015
2	Genetic Predisposition to Disease (Genetic Predisposition) 09/2013 - 01/2013
1	Liver Neoplasms (Liver Cancer) 11/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022
1	Lung Neoplasms (Lung Cancer) 11/2022
1	Metaplasia 09/2022
1	Idiopathic Pulmonary Fibrosis 04/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Thymoma (Thymic Carcinoma) 12/2021
1	Myasthenia Gravis 12/2021
1	Eosinophilia 12/2021

Drug/Important Bio-Agent (IBA)

12	dapagliflozinIBA 10/2022 - 01/2018
12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2007
9	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2013
7	CytokinesIBA 09/2022 - 01/2015
7	OvalbuminIBA 01/2022 - 01/2020
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2016
6	SodiumIBA 01/2022 - 01/2019
6	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2020 - 01/2015
6	ORALIT (ORS)IBA 12/2019 - 01/2015
5	PPAR gammaIBA 09/2020 - 01/2015
5	InterleukinsIBA 01/2020 - 10/2013
4	CTLA-4 AntigenIBA 07/2019 - 01/2014
4	LeptinIBA 01/2019 - 12/2017
3	CollagenIBA 04/2022 - 01/2020
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2019
3	Interleukin-13IBA 12/2021 - 01/2020
3	Interleukin-5 (Interleukin 5)IBA 12/2021 - 01/2020
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 12/2019
3	Gefitinib (Iressa)FDA Link 01/2021 - 01/2018
3	SymportersIBA 01/2021 - 01/2019
3	Insulin (Novolin)FDA Link 01/2021 - 01/2019
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2017
3	cediranib (AZD2171)IBA 01/2018 - 01/2017
2	Phosphotransferases (Kinase)IBA 04/2022 - 02/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2020
2	Methacholine Chloride (Methacholine)FDA Link 01/2022 - 02/2021
2	Long Noncoding RNAIBA 01/2022 - 01/2022
2	Immunoglobulin E (IgE)IBA 12/2021 - 11/2021
2	Interleukin-4 (Interleukin 4)IBA 08/2021 - 01/2020
2	ChemokinesIBA 07/2021 - 01/2020
2	Biological ProductsIBA 05/2021 - 12/2017
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2021 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Aryldialkylphosphatase (Paraoxonase)IBA 09/2020 - 11/2017
2	Drug CombinationsIBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 12/2017 - 02/2016
2	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2017 - 02/2014
2	Cyclin D1IBA 01/2016 - 01/2015
2	AZD 1480IBA 02/2015 - 01/2013
2	Ghrelin ReceptorsIBA 11/2007 - 10/2007
1	IsoflavonesIBA 09/2022
1	Estrogens (Estrogen)FDA Link 09/2022
1	TEA Domain Transcription FactorsIBA 04/2022
1	bisphenol FIBA 04/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2022
1	bis(4-hydroxyphenyl)sulfoneIBA 04/2022
1	CopperIBA 01/2022
1	baohuoside IIBA 01/2022
1	saxagliptin FDA Link 01/2022
1	5-hydroxysaxagliptinIBA 01/2022
1	anifrolumabIBA 01/2022
1	AntibodiesIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022

Therapy/Procedure

3	Therapeutics 09/2022 - 01/2021
2	Acupuncture Therapy 02/2021 - 01/2021
1	Glycemic Control 10/2022
1	Catgut 01/2022
1	Acupuncture Points (Acupuncture Point) 01/2022
1	Anesthesia 12/2021
1	Thymectomy 12/2021